LAS VEGAS, NV / ACCESS Newswire / June 24, 2026 /
Dear Shareholders,
Cytta continues to execute its strategy of creating shareholder value through the development, commercialization, and strategic ownership of proprietary technologies addressing the defense, public safety, critical infrastructure, communications, security, and autonomous systems markets.
Return to OTC Reporting Status
As previously disclosed, Cytta Corp (CYCA) licensed its SUPR compression technology to Reticulate Micro (RM) and received 5.1 million RM Class A shares. In an effort to directly benefit shareholders, the Company distributed the majority of these shares to shareholders and associates.
